Questions?
Contact Us

Boston Scientific will participate in the CIRSE 2017 congress having developed a dedicated scientific program in order to position itself as the partner of choice, delivering solutions for endovascular challenges.



Anchor component is added but not authored

Satellite Symposia

Sunday, September 17, 2017 | 11:30 – 12:30 | Auditorium 1 

Strategies for SFA intervention: Evidence, controversy and debate

Moderator: Prof. Marianne Brodmann, Austria

Topics Speakers
12m data from Ranger All Comer registry Dr. Michael Lichtenberg, Germany
My go to strategy: Drug coated balloon Prof. Gunnar Tepe, Germany 
My go to strategy: Drug Eluting Stent Prof. Yann Goueffic, France
My go to strategy: Atherectomy and Drug Elution Dr. Kostas Katsanos, Greece


 

Monday, September 18, 2017 | 13:00 – 14:00 | Auditorium 1

Deep Venous Interventions: Current state, future directions.

Moderator: Prof. Michael Lee, Ireland

Topics Speakers
A European view on ATTRACT trial to be announced
Keeping deep veins open: Imaging, intervention and surveillance
Dr. Rick De Graaf, Netherlands
Post Thrombotic Syndrome: Pathology and sequalae Dr. Marzia Lugli, Italy
Chronic venous disease: Healthcare burden and patient management Dr. Gerry O'Sullivan, Ireland

Innovation Room - Meet the Expert sessions

Boston Scientific has developed a dedicated Meet the Expert program in their Innovation room with focus on the following areas:

mCRC treatment with Embozene TANDEM™ loaded with Irinotecan – How I do it.

Dr. Franco Orsi, Italy
Sunday, September 17th | 14.00-15.00   
Monday, September 18th | 13.00-14.00  

HCC treatment with Embozene TANDEM™ loaded with Doxorubicin – How I do it.

Prof. Götz Richter, Germany
Sunday, September 17th | 11.00-12.00    
Monday, September 18th | 11.00-12.00  

HCC- Patient selection, procedural method and complication management (Language: German)

Prof. Abolmaali, Dresden, Germany; Dr. Lopez, Luzern, Switzerland; Prof. Wolf, Wien, Austria
Monday, September 18th | 12.00-13.00

 

What you need to know about UFE & Adenomyosis treatment.

Dr. Paul Lohle, The Netherlands
Saturday, September 16th | 11.30-12.30   
Monday, September 18th | 10.00-11.00    

How to begin an Emborrhoid practice.

Prof. Vincent Vidal, France
Saturday, September 16th | 13.00-14.00
Sunday, September 17th | 16.00-17.00    

What you need to know about Prostate Artery Embolization.

Prof. Florian Wolf, Austria
Sunday, September 17th | 13.00-14.00   
Tuesday, September 19th | 13.00-14.00 

Wireless repositioning: Direxion™ Torqueable Microcatheter in my daily practice.

Prof. Vincent Vidal, France
Sunday, September 17th | 9.00-10.00  

Vessel preparation for DCB with the JETSTREAM™ Atherectomy System – our current practice.

Dr. Tibor Balázs, Slovakia
Sunday, September 17th – 10.00-11.00    

Mastering venous stenting.

Dr. Marzia Lugli, Italy
Sunday, September 17th | 12.00-13.00   
Monday, September 18th | 9.00-10.00    

Thrombectomy with Angiojet™ system in clinical practice.

Prof. Dr. med. Christoph Binkert, Switzerland
Sunday, September 17th | 15.00-16.00   
Tuesday, September 19th | 10.00-11.00   

Boston Scientific Innovation Room will remain open for delegates who would like to learn more about our broad range of high performance solutions in the vascular and oncology fields.

To learn more about our Innovation Room program, please visit our booth.

Seats are limited. We encourage you to contact your Sales Representative to register.

Click here to expand

Abstract presentations

Monday, September 18th, 2017 | 16:15 - 17:15 | Auditorium 11

Twelve-month results of the RANGER SFA randomized study of the Ranger paclitaxel-coated balloon cathether: diabetic subgroup

C. Del Giudice, A. Willfort-Ehringer, H. Sievert, V. Geist, M. Lichtenberg, A. Sauguet, D. Scheinert

Monday, September 18th, 2017 | 17:30 - 18:30 | Auditorium 11

Thirty-six-month results from the MAJESTIC trial of the Eluvia drug-eluting vascular stent system

S. Müller-Hülsbeck K. Keirse T. Zeller H. Schroe J. Diaz-Cartelle


 

Discover more:


Stay up to date

Sign up to receive periodic emails update on Vascular Interventions and Interventional Oncology.

Top